Skip to the page

Data / Form D filings / Genome Medical Holding Co

Genome Medical Holding Co: Form D filings

Genome Medical Holding Co, a health care company in South San Francisco, CA, filed 4 Form D notices with the SEC between 2018 and 2024. The latest, on September 23, 2024, reports $75.3 million sold of a $75.3 million offering to 14 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
701 Gateway Blvd. Suite 380, South San Francisco, CA, 94080
Phone
(877) 688-0992
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1750159

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 23, 2024New notice$75,344,304$75,344,30414Sep 10, 2024sec.gov
Jul 10, 2020Amendment$14,999,998$14,410,805$589,19321Apr 6, 2020sec.gov
Jun 13, 2019New notice$22,999,990$22,999,99016May 30, 2019sec.gov
Aug 15, 2018New notice$223,200$223,2001May 31, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jill DaviesExecutive Officer, Director
Shaun RodriguezDirector
Elizabeth MorenoExecutive Officer
Alex ParkerDirector
Mark SylvesterExecutive Officer
Russell GlassDirector

Other health care companies in California that filed recently

Every Form D from the week of Sep 23, 2024 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Genome Medical Holding Co reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.